Resource Search

Results: 297

The EPP Expert Board members read - and select - for you the ‘must’ read books, articles and whitepapers for pricing practitioners.  
EPP Connect&More is another great source for pricing professionals, managed by a team of industry contributors. 
* Sign-up to receive the free monthly EPP Connect&More : here
* Some content in the EPP Content database is reserved for EPP Members only ;  sign-up : here


How AI is transforming Pricing

B2Me Pricing Forum 2019 - Monetized 

  • Author(s): Lena Chatchatrian
  • Uploaded on: 04/11/2019
  • Content Type: Articles

What is the best promotion strategy and its effects on pricing?

B2Me Pricing Forum 2019 - Monetized 

  • Author(s): Lena Chatchatrian
  • Uploaded on: 04/11/2019
  • Content Type: Articles

The Price Optimization Journey

B2Me Pricing Forum 2019 - Monetized 

  • Author(s): Lena Chatchatrian
  • Uploaded on: 04/11/2019
  • Content Type: Forum presentations

Pricing as a driver for digital transformation

B2Me Pricing Forum 2019 - Monetized 

  • Author(s): Lena Chatchatrian
  • Uploaded on: 04/11/2019
  • Content Type: Forum presentations

Change management: bring pricing to the core of your business to increase outcomes

B2Me Pricing Forum 2019 - Monetized 

  • Author(s): Lena Chatchatrian
  • Uploaded on: 04/11/2019
  • Content Type: Forum presentations

EPP Thought Leadership Series 1/2019

Edition 1/2019 : The evolving landscape of Biosimilars and it”s impact on the public procurement and Tendering environment

Highpoint, an IQVIA company, has conducted various analysis to assess the impact of tenders for biosimilars and observed recent market trends as well as manufacturer behaviors to capture the subtle changes. Our findings translate into a comprehensive view on how companies could improve their bidding and tender strategy to succeed in this space. lastly, we provide our outlook on this topic emphasizing the importance for all stakeholders to find the right balance between cost containment for payers and sustainability for manufacturers to ensure that ultimately, patients and physicians will have multiple treatment options available.

The EPP® Thought Leadership Series provide insights from pricing leaders around the globe. When a new insight breaks, these pricing leaders already think of the unanswered questions and the story behind the story.  These people want to inspire you to act - to take the next step in your journey. With these series, we help to take the right actions.

  • Author(s): EPP Thought Leadership Series
  • Uploaded on: 26/07/2019
  • Content Type: Articles

EPP Thought Leadership Series 2/2019

Edition 2/2019: 7 Steps for Success in Tender Management

Change and taking action usually starts with either inspiration or desperation. You could be inspired and intrigued by the opportunities and possibilities that something offers. Or you are desperate and disappointed about the fact that things do not go the way you want them to go and you are almost forced to change something. This also applies to Tendering.

 The EPP® Thought Leadership Series provide insights from pricing leaders around the globe. When a new insight breaks, these pricing leaders already think of the unanswered questions and the story behind the story.  These people want to inspire you to act - to take the next step in your journey. With these series, we help to take the right actions.

 

 

  • Author(s): Lena Chatchatrian
  • Uploaded on: 24/07/2019
  • Content Type: Articles

Tendering and Contracting - Industry Trends

With 25% of the pharmaceutical market worldwide going through some form of T&C, you are far from alone. We expect, in both developed and emerging countries that trend to not only continue, but increase. Consequently, the importance for Life Sciences companies to build a succesful tendering and contracting governance globally increases as well. 

  • Author(s): Lena Chatchatrian
  • Uploaded on: 01/08/2019
  • Content Type: Articles

Insights into Public Procurement for Life Sciences Companies

 

With public procurement growing across industries, Life Sciences companies are no exception to the rule. Indeed, 25% of the pharmaceutical market is now considered to be traded through some form of tender. Tenders are a specific form of centralized procurement where government or any level of health authorities are enforcing competition for a product.

 

  • Author(s): Lena Chatchatrian
  • Uploaded on: 16/04/2019
  • Content Type: Articles

Video : The Augmented Pricing Manager

Presentation of Manu Carricano on the 13th EPP Global Pricing Forum.

CLICK AND WATCH THE VIDEO BELOW

  • Author(s): Manu Carricano
  • Uploaded on: 11/10/2018
  • Content Type: Videos
Cron Job Starts